Cargando…
Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial
BACKGROUND: Despite decades of investigation, the balance of clinical risks and benefits of fluid supplementation with starch remain unresolved. Patient-centered outcomes have not been well explored in a “real-world” trial in cardiac surgery. OBJECTIVE: We sought to compare a starch-based fluid stra...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388134/ https://www.ncbi.nlm.nih.gov/pubmed/32782813 http://dx.doi.org/10.1177/2054358120940434 |
_version_ | 1783564255672401920 |
---|---|
author | Nagpal, A. Dave Cowan, Andrea Li, Linna Nusca, Graeme Guo, Linrui Novick, Richard J. Harle, Chris C. House, Andrew A. Fox, Stephanie Jones, Philip M. |
author_facet | Nagpal, A. Dave Cowan, Andrea Li, Linna Nusca, Graeme Guo, Linrui Novick, Richard J. Harle, Chris C. House, Andrew A. Fox, Stephanie Jones, Philip M. |
author_sort | Nagpal, A. Dave |
collection | PubMed |
description | BACKGROUND: Despite decades of investigation, the balance of clinical risks and benefits of fluid supplementation with starch remain unresolved. Patient-centered outcomes have not been well explored in a “real-world” trial in cardiac surgery. OBJECTIVE: We sought to compare a starch-based fluid strategy with a saline-based fluid strategy in the cardiac surgery patient. DESIGN: A pragmatic blinded randomized controlled trial comparing starch-based with saline-based fluid strategy. SETTING: A large tertiary academic center in London Ontario between September 2009 and February 2011. PARTICIPANTS: Patients undergoing planned, isolated coronary revascularization. MEASUREMENTS: Serum creatinine and patient weight were measured daily postoperatively. METHODS: Patients were randomized to receive 6% hydroxyethyl starch (Voluven) or saline for perioperative fluid requirements. Fluid administration was not protocolized. Co-primary outcomes were incidence of acute kidney injury (AKI) and maximum postoperative weight gain. Secondary outcomes included bleeding, transfusion, inotropic and ventilator support, and fluid utilization. RESULTS: The study was prematurely terminated due to resource limitations. A total of 69 patients (19% female, mean age = 65) were randomized. Using RIFLE criteria for AKI, “risk” occurred in 12 patients in each group (risk ratio [RR] = 1.0; 95% confidence interval [CI] = 0.5-1.9; P = 1.00), whereas “injury” occurred in 7 of 35 (20%) and 3 of 34 (9%) of patients in the starch and saline groups, respectively (RR = 2.3; 95% CI = 0.6-8.1; P = .31). Maximum weight gain, bleeding and blood product usage, and overall fluid requirement were similar between groups. LIMITATIONS: The study had to be prematurely terminated due to resource limitations which led to a small sample size which was not sufficiently powered to detect a difference in the primary outcomes. CONCLUSIONS: This pragmatic double-blinded randomized controlled trial revealed a number of interesting hypothesis-generating trends and confirmed the feasibility of undertaking a logistically complex trial in a pragmatic fashion. |
format | Online Article Text |
id | pubmed-7388134 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-73881342020-08-10 Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial Nagpal, A. Dave Cowan, Andrea Li, Linna Nusca, Graeme Guo, Linrui Novick, Richard J. Harle, Chris C. House, Andrew A. Fox, Stephanie Jones, Philip M. Can J Kidney Health Dis Original Clinical Research Quantitative BACKGROUND: Despite decades of investigation, the balance of clinical risks and benefits of fluid supplementation with starch remain unresolved. Patient-centered outcomes have not been well explored in a “real-world” trial in cardiac surgery. OBJECTIVE: We sought to compare a starch-based fluid strategy with a saline-based fluid strategy in the cardiac surgery patient. DESIGN: A pragmatic blinded randomized controlled trial comparing starch-based with saline-based fluid strategy. SETTING: A large tertiary academic center in London Ontario between September 2009 and February 2011. PARTICIPANTS: Patients undergoing planned, isolated coronary revascularization. MEASUREMENTS: Serum creatinine and patient weight were measured daily postoperatively. METHODS: Patients were randomized to receive 6% hydroxyethyl starch (Voluven) or saline for perioperative fluid requirements. Fluid administration was not protocolized. Co-primary outcomes were incidence of acute kidney injury (AKI) and maximum postoperative weight gain. Secondary outcomes included bleeding, transfusion, inotropic and ventilator support, and fluid utilization. RESULTS: The study was prematurely terminated due to resource limitations. A total of 69 patients (19% female, mean age = 65) were randomized. Using RIFLE criteria for AKI, “risk” occurred in 12 patients in each group (risk ratio [RR] = 1.0; 95% confidence interval [CI] = 0.5-1.9; P = 1.00), whereas “injury” occurred in 7 of 35 (20%) and 3 of 34 (9%) of patients in the starch and saline groups, respectively (RR = 2.3; 95% CI = 0.6-8.1; P = .31). Maximum weight gain, bleeding and blood product usage, and overall fluid requirement were similar between groups. LIMITATIONS: The study had to be prematurely terminated due to resource limitations which led to a small sample size which was not sufficiently powered to detect a difference in the primary outcomes. CONCLUSIONS: This pragmatic double-blinded randomized controlled trial revealed a number of interesting hypothesis-generating trends and confirmed the feasibility of undertaking a logistically complex trial in a pragmatic fashion. SAGE Publications 2020-07-28 /pmc/articles/PMC7388134/ /pubmed/32782813 http://dx.doi.org/10.1177/2054358120940434 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Clinical Research Quantitative Nagpal, A. Dave Cowan, Andrea Li, Linna Nusca, Graeme Guo, Linrui Novick, Richard J. Harle, Chris C. House, Andrew A. Fox, Stephanie Jones, Philip M. Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial |
title | Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized
Controlled Trial |
title_full | Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized
Controlled Trial |
title_fullStr | Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized
Controlled Trial |
title_full_unstemmed | Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized
Controlled Trial |
title_short | Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized
Controlled Trial |
title_sort | starch or saline after cardiac surgery: a double-blinded randomized
controlled trial |
topic | Original Clinical Research Quantitative |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388134/ https://www.ncbi.nlm.nih.gov/pubmed/32782813 http://dx.doi.org/10.1177/2054358120940434 |
work_keys_str_mv | AT nagpaladave starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial AT cowanandrea starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial AT lilinna starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial AT nuscagraeme starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial AT guolinrui starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial AT novickrichardj starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial AT harlechrisc starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial AT houseandrewa starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial AT foxstephanie starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial AT jonesphilipm starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial |